Citadel Advisors
NMRA icon

Citadel Advisors’s Neumora Therapeutics NMRA Stock Holding History

Citadel Advisors’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70K Buy
35,900
+23,500
+190% +$60.9K ﹤0.01% 12253
2025
Q4 		$22.2K Sell
12,400
-31,300
-72% -$68.5K ﹤0.01% 12314
2025
Q3 		$79.5K Sell
43,700
-10,800
-20% -$17.5K ﹤0.01% 11979
2025
Q2 		$40K Sell
54,500
-48,100
-47% -$36.4K ﹤0.01% 11883
2025
Q1 		$103K Sell
102,600
-192,800
-65% -$330K ﹤0.01% 11421
2024
Q4 		$3.13M Buy
295,400
+221,600
+300% +$2.66M ﹤0.01% 4769
2024
Q3 		$975K Buy
73,800
+45,100
+157% +$526K ﹤0.01% 6918
2024
Q2 		$282K Buy
28,700
+23,900
+498% +$247K ﹤0.01% 9261
2024
Q1 		$66K Buy
4,800
+4,100
+586% +$66.3K ﹤0.01% 11890
2023
Q4 		$11.9K Buy
+700
New +$8.59K ﹤0.01% 13015

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return